OptimizeRx: Q4 Earnings Report Indicates Caution For 2026

2026-03-10 10:10:22 ET

OptimizeRx ( OPRX ) had a rough few months as the stock dropped from the $20s down to the single digits. A lot of the sell-off has to do with the AI-fear trade, which is probably overdone. OPRX stated that their business should have minimal disruption from AI . However, all may not be well with OPRX. The recent Q4 2025 earnings report provides insights into why there was a sell-off reaction. The report shows some headwinds for the 2026 outlook....

Read the full article on Seeking Alpha

For further details see: